Abstract:Schizophrenia is genetically heterogeneous and comorbid with many conditions. In this study, we explored polygenic scores (PGSs) from genetically related conditions and traits to predict schizophrenia diagnosis using both logistic regression and deep neural network (DNN) models. We used the combined Molecular Genetics of Schizophrenia and Swedish Schizophrenia Case Control Study (MGS+SSCCS) data for training and testing the models, and used the Clinical Antipsychotic Trials for Intervention Effectiveness (CATI… Show more
“…The AUCs from these studies varied substantially, from 0.54 to 0.95. The AIO results reported here fared better than most the studies reviewed, including our previous study, 18 which used not only the PRSs of schizophrenia but also PRSs from other comorbid traits. These results indicated that genetic data, once transformed into AIOs, could be used effectively to classify the diagnosed patients and unaffected controls.…”
Section: Discussioncontrasting
confidence: 64%
“…In the literature, there were multiple studies that used genetic markers to predict schizophrenia diagnosis, 17 including a study from our group. 18 Most of these studies used an SVM algorithm, and the variables were mostly individual SNVs. Only two studies, one of which was our previous study, used external validation samples.…”
Highlights d Introduce a technique to transform genomics data into AIOs d Apply CNN algorithms to classify genomics derived AIOs d Showcase the technique with GWAS-selected SNVs to classify schizophrenia diagnosis
“…The AUCs from these studies varied substantially, from 0.54 to 0.95. The AIO results reported here fared better than most the studies reviewed, including our previous study, 18 which used not only the PRSs of schizophrenia but also PRSs from other comorbid traits. These results indicated that genetic data, once transformed into AIOs, could be used effectively to classify the diagnosed patients and unaffected controls.…”
Section: Discussioncontrasting
confidence: 64%
“…In the literature, there were multiple studies that used genetic markers to predict schizophrenia diagnosis, 17 including a study from our group. 18 Most of these studies used an SVM algorithm, and the variables were mostly individual SNVs. Only two studies, one of which was our previous study, used external validation samples.…”
Highlights d Introduce a technique to transform genomics data into AIOs d Apply CNN algorithms to classify genomics derived AIOs d Showcase the technique with GWAS-selected SNVs to classify schizophrenia diagnosis
“…One publication [3] used both manual and random elements for search, and is counted in both categories. Manual tuning by Chen et al (2019) is implied through reported values which were attempted for hyperparameters, but not explicitly stated [5]. Hyperparameters searched systematically using a given set of values are denoted as grid search.…”
“…These results still need to be replicated by other cohorts or similar genetic studies, but they suggest different approaches to discover genetic backgrounds in early-onset psychosis and those in late-onset psychosis. There is a high amount of genetic research related to schizophrenia [ 61 , 62 , 63 ], but the underlying difference between schizophrenic individuals with the typical onset age and those with late-onset schizophrenia means that more investigation is needed in this field. Another approach to find the pathophysiology of late-onset psychosis targets the shared liability between late-onset psychosis and the neurodegenerative disorder accompanying psychotic symptoms.…”
Section: Precision Medicine In Late-onset Psychosismentioning
Psychosis can include schizophrenia, mood disorders with psychotic features, delusional disorder, active delirium, and neurodegenerative disorders accompanied by various psychotic symptoms. Late-onset psychosis requires careful intervention due to the greater associated risks of secondary psychosis; higher morbidity and mortality rates than early-onset psychosis; and complicated treatment considerations due to the higher incidence of adverse effects, even with the black box warning against antipsychotics. Pharmacological treatment, including antipsychotics, should be carefully initiated with the lowest dosage for short-term efficacy and monitoring of adverse side effects. Further research involving larger samples, more trials with different countries working in consortia, and unified operational definitions for diagnosis will help elaborate the clinical characteristics of late-onset psychosis and lead to the development of treatment approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.